The Trump administration cancelled about $500 million for research into mRNA vaccines. The move slows progress in using the technology to prevent a future pandemic or treat disease, experts say.

A biotech that lost federal funding Tuesday following Health Secretary Robert F. Kennedy Jr.’s edict that his agency’s ...

This was one in a continuing line of moves that has put RFK Jr.'s vaccine skepticism into public policy, though scientists ...

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

Kennedy said Tuesday that the terminated contracts were worth nearly $500 million. Among them is an award to the University of Texas Medical Branch and the biotechnology company Moderna to develop an ...

The targeting of the vaccine technology once considered revolutionary follows intense criticism by conservatives and ...

The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like COVID-19 and the flu. Robert F. Kennedy ...

The Health and Human Services secretary cancelled nearly $500 million in contracts related to the development of future ...

Research shows mRNA vaccines saved millions of lives during the COVID-19 pandemic. Now scientists are using that Nobel ...

The Department of Health and Human Services (HHS) is winding down its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA), the agency ...

In a note to employees on Thursday, Moderna Inc. said it was laying off about 10% of its global workforce as part of the ...

Discover key takeaways from Moderna's Q2 2025 earnings call, including FDA approvals, cost reductions, pipeline strategies, and financial updates.